1) Pure red cell aplasia
纯红细胞再生障碍性贫血
1.
Thymoma associated with pure red cell aplasia: a cases report and review of Chinese literatures;
胸腺瘤合并单纯红细胞再生障碍性贫血1例及文献复习
2.
Clinic analysis of 24 cases with pure red cell aplasia;
24例纯红细胞再生障碍性贫血临床分析
3.
Objective:To investigate the diagnosis, etiology, pathogenesis and therapy of pure red cell aplasia (PRCA).
目的 :探讨纯红细胞再生障碍性贫血的病因、发病机制、诊断和治疗。
2) pure red cell aplasia (PRCA)
单纯红细胞再生障碍性贫血
1.
Objective: to understand the pathogenesis , clinical features, methodes of diagnosis of thymoma associated with pure red cell aplasia (PRCA) and to evaluate the outcome of the therapy.
目的 探讨胸腺瘤合并单纯红细胞再生障碍性贫血的发病机理、临床表现、诊断方法和有效的治疗方法。
3) pure erythroid aplasia
单纯红系再生障碍性贫血
1.
The aim of this study was to investigate the curative effects of amifostine(AMF) combined with recombinant human β-erythropoietin(rhβ-EPO) on patients with pure erythroid aplasia(PEA).
本研究旨在观察氨磷汀(AMF)联合重组人β红系生成素(rhβ-EPO)对单纯红系再生障碍性贫血(PEA)患者的近期疗效及副作用。
4) pure red cell aplasia
纯红细胞再生障碍
1.
Immunosuppressive therapy for pure red cell aplasia and aplastic anemia;
纯红细胞再生障碍和再生障碍性贫血的免疫抑制治疗
2.
Six out of 20 patients undergoing a major ABO incompatible allogeneic stem cell transplantation(allo HSCT) developed pure red cell aplasia(PRCA), which did not show any effects on granulocyte and platelet engraftment, and incidence of grade Ⅱ-Ⅳ aGVHD.
20例主要ABO血型不合异基因造血干细胞移植 (allo HSCT)患者中 ,6例发生纯红细胞再生障碍(PRCA)。
5) congenital dyserythropoietic anemia-type Ⅰ
先天性红细胞生成障碍性贫血Ⅰ型
6) Aplastic anemia
再生障碍性贫血
1.
Death from aplastic anemia and thyroid crisis due to inappropriate treatment with methimazole;
甲巯咪唑治疗不当引起再生障碍性贫血和甲状腺危象导致死亡
2.
Expression of TCR-zeta chain in patients with aplastic anemia and polycythemia vera;
再生障碍性贫血和真性红细胞增多症患者TCRζ链基因表达情况
3.
T-cell suppression mediated by mesenchymal stem cells in patients with chronic aplastic anemia;
慢性再生障碍性贫血患者间充质干细胞对T细胞的抑制作用
补充资料：小细胞低色素性贫血
小细胞低色素性贫血
红细胞体积比正常红细胞小，着色浅，红细胞平均容积(MCV）＜80fl，平均血红蛋白浓度(MCHC）＜30%。包括缺铁性贫血、地中海贫血、慢性感染性贫血和铁粒幼细胞贫血等。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条